{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:10:36Z","timestamp":1788261036904,"version":"build-2803163510"},"reference-count":131,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.bbmt.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T02:02:18Z","timestamp":1567735338000},"page":"e363-e374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Hematopoietic Stem Cell Transplantation to Treat Leukodystrophies: Clinical Practice Guidelines from the Hunter's Hope Leukodystrophy Care Network"],"prefix":"10.1016","volume":"25","author":[{"given":"Kristin M.","family":"Page","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth O.","family":"Stenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Kester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Biffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Fatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Kurtzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.09.003_bib0001","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2011-01-329235","article-title":"Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report","volume":"118","author":"Miller","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0002","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJM199006283222607","article-title":"Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation","volume":"322","author":"Aubourg","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0003","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood-2003-10-3402","article-title":"Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999","volume":"104","author":"Peters","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0004","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/bloodadvances.2017010645","article-title":"Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies","volume":"2","author":"van den Broek","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0005","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(00)02629-5","article-title":"Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy","volume":"356","author":"Shapiro","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0006","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0007","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00431-011-1401-1","article-title":"Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison's disease improves survival and neurological outcomes","volume":"170","author":"Polgreen","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0008","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jpeds.2004.10.067","article-title":"Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening","volume":"146","author":"Dubey","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0009","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2016.2067","article-title":"Long-term outcome of allogeneic hematopoietic stem cell transplantation in patients with juvenile metachromatic leukodystrophy compared with nontransplanted control patients","volume":"73","author":"Groeschel","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13023-015-0313-y","article-title":"Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report","volume":"10","author":"Boucher","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0011","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1182\/blood-2016-03-708479","article-title":"Efficacy of hematopoietic cell transplantation in metachromatic leukodystrophy: the Dutch experience","volume":"127","author":"van Rappard","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0012","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbmt.2013.01.010","article-title":"Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy","volume":"19","author":"Martin","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0013","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1212\/WNL.0000000000004418","article-title":"Developmental outcomes of cord blood transplantation for Krabbe disease: A 15-year study","volume":"89","author":"Wright","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0014","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00019052-199904000-00007","volume":"12","author":"Krivit","year":"1999","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1126\/science.169.3941.141","article-title":"Inborn errors of mucopolysaccharide metabolism","volume":"169","author":"Neufeld","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0016","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20180247","article-title":"Peripherally derived macrophages can engraft the brain independent of irradiation and maintain an identity distinct from microglia","volume":"215","author":"Cronk","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0017","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/nm1201-1356","article-title":"Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment","volume":"7","author":"Priller","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0018","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1073\/pnas.0306431101","article-title":"Human CD34+cells differentiate into microglia and express recombinant therapeutic protein","volume":"101","author":"Asheuer","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0019","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jns.2003.11.006","article-title":"Therapeutic effects of normal cells on ABCD1 deficient cells in vitro and hematopoietic cell transplantation in the X-ALD mouse model","volume":"218","author":"Yamada","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0020","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archneur.64.5.noc60105","article-title":"Genotype and protein expression after bone marrow transplantation for adrenoleukodystrophy","volume":"64","author":"Schonberger","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0021","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/096368979500400409","article-title":"Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases","volume":"4","author":"Krivit","year":"1995","journal-title":"Cell Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0022","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.bbmt.2018.06.020","article-title":"Long-term functional outcomes after hematopoietic stem cell transplant for early infantile Krabbe disease","volume":"24","author":"Allewelt","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0023","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1212\/WNL.0000000000002811","article-title":"Gallbladder and the risk of polyps and carcinoma in metachromatic leukodystrophy","volume":"87","author":"van Rappard","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0024","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jss.2016.08.081","article-title":"Gallbladder abnormalities in children with metachromatic leukodystrophy","volume":"208","author":"Kim","year":"2017","journal-title":"J Surg Res"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0025","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1200\/JCO.2004.02.189","article-title":"Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry","volume":"22","author":"Eapen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0026","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.bbmt.2018.08.010","article-title":"Bone marrow versus peripheral blood from unrelated donors for children and adolescents with acute leukemia","volume":"24","author":"Keesler","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0027","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41409-017-0015-2","article-title":"Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation","volume":"53","author":"Fernandes","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0028","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U","article-title":"Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls","volume":"45","author":"Moser","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0029","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ymgme.2011.11.001","article-title":"Adrenoleukodystrophy in female heterozygotes: underrecognized and undertreated","volume":"105","author":"Jangouk","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-1172-9-6","article-title":"Neurological impairment among heterozygote women for X-linked adrenoleukodystrophy: a case control study on a clinical, neurophysiological and biochemical characteristics","volume":"9","author":"Habekost","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0031","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V89.11.4226","article-title":"Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose","volume":"89","author":"Sierra","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0032","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1182\/blood-2002-01-0339","article-title":"Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation","volume":"100","author":"Dominietto","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0033","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1200\/JCO.2002.11.058","article-title":"Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey","volume":"20","author":"Rocha","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0034","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s10545-005-4138-z","article-title":"Globoid cell leukodystrophy (Krabbe disease): normal umbilical cord blood galactocerebrosidase activity and polymorphic mutations","volume":"28","author":"Raghavan","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.bmt.1702185","article-title":"Measurements from normal umbilical cord blood of four lysosomal enzymatic activities: alpha-L-iduronidase (Hurler), galactocerebrosidase (globoid cell leukodystrophy), arylsulfatase A (metachromatic leukodystrophy), arylsulfatase B (Maroteaux-Lamy)","volume":"25","author":"deGasperi","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0036","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbmt.2005.09.016","article-title":"Results of the Cord Blood Transplantation Study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases","volume":"12","author":"Martin","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0037","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1405584","article-title":"One-unit versus two-unit cord-blood transplantation for hematologic cancers","volume":"371","author":"Wagner","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0038","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2141.2009.07883.x","article-title":"Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors","volume":"147","author":"Rocha","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0039","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41409-017-0055-7","article-title":"Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT","volume":"53","author":"Buchbinder","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0040","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/mt.2013.29","article-title":"Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation","volume":"21","author":"Wilkinson","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0041","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1073\/pnas.1205858109","article-title":"Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation","volume":"109","author":"Capotondo","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0042","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0043","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2008-03-140830","article-title":"Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes","volume":"112","author":"Prasad","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0044","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bbmt.2013.11.027","article-title":"Fludarabine and exposure-targeted busulfan compares favorably with busulfan\/cyclophosphamide-based regimens in pediatric hematopoietic cell transplantation: maintaining efficacy with less toxicity","volume":"20","author":"Bartelink","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/11598180-000000000-00000","article-title":"Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: towards individualized dosing","volume":"51","author":"Bartelink","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0046","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bmt.1705435","article-title":"Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy","volume":"38","author":"Lee","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0047","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbspin.2010.02.025","article-title":"Glucocorticoid-induced myopathy","volume":"78","author":"Pereira","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0048","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0049","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.bbmt.2018.01.017","article-title":"Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's list of 5 tests and treatments to question in blood and marrow transplantation","volume":"24","author":"Bhella","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0050","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bbmt.2016.10.001","article-title":"National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: the Immune Dysregulation and Pathobiology Working Group report","volume":"23","author":"Gea-Banacloche","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0051","unstructured":"World Health Organization. International Classification of Functioning, Disability and Health. https:\/\/www.who.int\/classifications\/icf\/en\/ Accessed October 1, 2018."},{"key":"10.1016\/j.bbmt.2019.09.003_bib0052","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40263-015-0248-9","article-title":"Levetiracetam monotherapy in children with epilepsy: a systematic review","volume":"29","author":"Weijenberg","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0053","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13023-018-0766-x","article-title":"Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease","volume":"13","author":"Kwon","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0054","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1016\/S2352-3026(16)30114-4","article-title":"Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis","volume":"3","author":"Bartelink","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0055","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1158\/1078-0432.CCR-13-1960","article-title":"Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and bayesian dose personalization","volume":"20","author":"McCune","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0056","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/sj.bmt.1704209","article-title":"Intravenous busulfan for allogeneic hematopoietic stem cell transplantation in infants: clinical and pharmacokinetic results","volume":"32","author":"Dalle","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0057","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.bmt.1702700","article-title":"Retrospective appraisal of busulfan dose adjustment in children","volume":"26","author":"Dupuis","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0058","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbmt.2005.05.003","article-title":"Busulfan\/melphalan\/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation Study (COBLT) experience","volume":"11","author":"Wall","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0059","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbmt.2016.10.019","article-title":"Allele-level HLA matching impacts key outcomes following umbilical cord blood transplantation for inherited metabolic disorders","volume":"23","author":"Mallhi","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0060","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/lt.24743","article-title":"Living donor liver transplantation during the first 3 months of life","volume":"23","author":"Kasahara","year":"2017","journal-title":"Liver Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0061","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/petr.12686","article-title":"The second report of the Nordic Pediatric Renal Transplantation Registry 1997-2012: more infant recipients and improved graft survivals","volume":"20","author":"Jahnukainen","year":"2016","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0062","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jamapediatrics.2014.1360","article-title":"Blood transfusion and breast milk transmission of cytomegalovirus in very low birth weight infants","volume":"168","author":"Josephson","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0063","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.101","article-title":"Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening","volume":"49","author":"Bezman","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0064","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrendo.2016.90","article-title":"Adrenoleukodystrophy\u2014neuroendocrine pathogenesis and redefinition of natural history","volume":"12","author":"Kemp","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0065","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/bmt.2012.33","article-title":"No evidence for the reversal of adrenal failure after hematopoietic cell transplantation in X-linked adrenoleukodystrophy","volume":"47","author":"Petryk","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0066","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ecl.2016.01.003","article-title":"Endocrine dysfunction in X-linked adrenoleukodystrophy","volume":"45","author":"Burtman","year":"2016","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0067","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ejpn.2017.02.006","article-title":"Long-term outcome of patients with X-linked adrenoleukodystrophy: a retrospective cohort study","volume":"21","author":"Tran","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0068","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1531-8249(20010201)49:2<186::AID-ANA38>3.0.CO;2-R","article-title":"Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy","volume":"49","author":"van Geel","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0069","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/jamaneurol.2017.0013","article-title":"Neurocognitive trajectory of boys who received a hematopoietic stem cell transplant at an early stage of childhood cerebral adrenoleukodystrophy","volume":"74","author":"Pierpont","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0070","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbmt.2018.09.036","article-title":"Survival and functional outcomes in boys with cerebral adrenoleukodystrophy with and without hematopoietic stem cell transplantation","volume":"25","author":"Raymond","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0071","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ymgme.2015.02.002","article-title":"Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelines","volume":"114","author":"Vogel","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0072","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jnnp.63.1.4","article-title":"X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy","volume":"63","author":"van Geel","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0073","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-1-4419-9072-3_47","article-title":"Evaluation of the preventive effect of glyceryl trioleate-trierucate (\"Lorenzo's oil\") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials","volume":"544","author":"Moser","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0074","first-page":"1761","article-title":"Adrenoleukodystrophy: a scoring method for brain MR observations","volume":"15","author":"Loes","year":"1994","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1212\/01.WNL.0000079050.91337.83","article-title":"Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy","volume":"61","author":"Loes","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0076","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3174\/ajnr.A4500","article-title":"Intensity of MRI gadolinium enhancement in cerebral adrenoleukodystrophy: a biomarker for inflammation and predictor of outcome following transplantation in higher risk patients","volume":"37","author":"Miller","year":"2016","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0077","first-page":"839","article-title":"X-linked adrenoleukodystrophy: the role of contrast-enhanced mr imaging in predicting disease progression","volume":"21","author":"Melhem","year":"2000","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0078","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1148\/radiol.2251011040","article-title":"Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience","volume":"225","author":"Eichler","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0079","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00431-002-1097-3","article-title":"Haematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy","volume":"162","author":"Baumann","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-7-51","article-title":"X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management","volume":"7","author":"Engelen","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0081","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10545-014-9797-1","article-title":"Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study","volume":"38","author":"van Geel","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0082","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awx016","article-title":"Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy","volume":"140","author":"Kuhl","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0083","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jimd.12044","article-title":"Allogeneic haematopoietic stem cell transplantation with myeloablative conditioning for adult cerebral X-linked adrenoleukodystrophy","volume":"42","author":"Waldhuter","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0084","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ymgme.2013.12.009","article-title":"Krabbe disease: are certain mutations disease-causing only when specific polymorphisms are present or when inherited in trans with specific second mutations","volume":"111","author":"Wenger","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0085","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10545-015-9822-z","article-title":"Measurement of psychosine in dried blood spots\u2013a possible improvement to newborn screening programs for Krabbe disease","volume":"38","author":"Turgeon","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0086","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ymgme.2017.05.015","article-title":"Psychosine, a marker of Krabbe phenotype and treatment effect","volume":"121","author":"Escolar","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0087","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1373\/clinchem.2016.264952","article-title":"Lymphocyte galactocerebrosidase activity by LC-MS\/MS for post-newborn screening evaluation of Krabbe disease","volume":"63","author":"Liao","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0088","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pediatrneurol.2011.05.007","article-title":"Early infantile Krabbe disease: results of the World-Wide Krabbe Registry","volume":"45","author":"Duffner","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0089","doi-asserted-by":"crossref","first-page":"e879","DOI":"10.1542\/peds.2006-0747","article-title":"A staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation","volume":"118","author":"Escolar","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0090","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/gim.2016.35","article-title":"Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State","volume":"18","author":"Wasserstein","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0091","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/jnr.23769","article-title":"Diffusion tensor imaging: a biomarker of outcome in Krabbe's disease","volume":"94","author":"Poretti","year":"2016","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0092","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.clinph.2004.02.022","article-title":"Brain-stem auditory and visual evoked potentials in children with Krabbe disease","volume":"115","author":"Aldosari","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0093","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1399-0004.2010.01572.x","article-title":"Krabbe leukodystrophy in a selected population with high rate of late onset forms: longer survival linked to c.121G>A (p.Gly41Ser) mutation","volume":"80","author":"Fiumara","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0094","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/humu.9500","article-title":"A single mutation in the GALC gene is responsible for the majority of late onset Krabbe disease patients in the Catania (Sicily, Italy) region","volume":"28","author":"Lissens","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.gene.2013.11.003","article-title":"Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form","volume":"534","author":"Hossain","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0096","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000112167","article-title":"Symptomatology of late onset Krabbe's leukodystrophy: the European experience","volume":"13","author":"Lyon","year":"1991","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0097","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10072-012-0956-6","article-title":"Peripheral neuropathy in late-onset Krabbe disease: report of three cases","volume":"34","author":"Malandrini","year":"2013","journal-title":"Neurol Sci"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0098","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pediatrneurol.2012.02.023","article-title":"Later onset phenotypes of Krabbe disease: results of the world-wide registry","volume":"46","author":"Duffner","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0099","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/01.WNL.0000134651.38196.F8","article-title":"Krabbe disease: neurophysiologic studies and MRI correlations","volume":"63","author":"Husain","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0100","first-page":"316","article-title":"Globoid cell leukodystrophy: distinguishing early-onset from late-onset disease using a brain MR imaging scoring method","volume":"20","author":"Loes","year":"1999","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0101","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4137\/JCM.S40470","article-title":"Predominant corticospinal tract involvement in a late infant with Krabbe disease","volume":"7","author":"Yoshimura","year":"2016","journal-title":"Jpn Clin Med"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0102","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.bmt.1705984","article-title":"Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease","volume":"41","author":"Lim","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0103","first-page":"57","article-title":"Stem cell transplantation for adult-onset Krabbe disease: report of a case","volume":"10","author":"Sharp","year":"2013","journal-title":"JIMD Rep"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0104","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/jnr.23914","article-title":"Challenge of phenotype estimation for optimal treatment of Krabbe disease","volume":"94","author":"Sakai","year":"2016","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0105","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJM199804163381605","article-title":"Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy","volume":"338","author":"Krivit","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0106","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jon.12502","article-title":"Hematopoietic stem cell transplantation in late-onset Krabbe disease: no evidence of worsening demyelination and axonal loss 4 years post-allograft","volume":"28","author":"Laule","year":"2018","journal-title":"J Neuroimag"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0107","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1399-0004.2008.01058.x","article-title":"Metachromatic leukodystrophy\u2014mutation analysis provides further evidence of genotype-phenotype correlation","volume":"74","author":"Biffi","year":"2008","journal-title":"Clin Genet"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0108","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.gene.2013.11.062","article-title":"Critical issues for the proper diagnosis of metachromatic leukodystrophy","volume":"537","author":"Lorioli","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0109","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.bmt.1705581","article-title":"Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progression","volume":"39","author":"Bredius","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0110","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/jamaneurol.2013.629","article-title":"Improvement of white matter changes on neuroimaging modalities after stem cell transplant in metachromatic leukodystrophy","volume":"70","author":"van Egmond","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0111","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1469-8749.2010.03821.x","article-title":"Development and reliability of a classification system for gross motor function in children with metachromatic leucodystrophy","volume":"53","author":"Kehrer","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0112","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.3174\/ajnr.A1739","article-title":"Metachromatic leukodystrophy: a scoring system for brain MR imaging observations","volume":"30","author":"Eichler","year":"2009","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0113","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/jnnp-2017-316364","article-title":"Quantitative MR spectroscopic imaging in metachromatic leukodystrophy: value for prognosis and treatment","volume":"89","author":"van Rappard","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0114","doi-asserted-by":"crossref","first-page":"24579","DOI":"10.1038\/srep24579","article-title":"Cerebral spinal fluid levels of cytokines are elevated in patients with metachromatic leukodystrophy","volume":"6","author":"Thibert","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/acn3.193","article-title":"Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy","volume":"2","author":"Dali","year":"2015","journal-title":"Ann Clin Translat Neurol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0116","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymgme.2015.02.009","article-title":"Abnormalities of acid-base balance and predisposition to metabolic acidosis in Metachromatic Leukodystrophy patients","volume":"115","author":"Lorioli","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0117","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.bbmt.2016.05.024","article-title":"Late effects after umbilical cord blood transplantation in very young children after busulfan-based, myeloablative conditioning","volume":"22","author":"Allewelt","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0118","unstructured":"Children's Oncology Group. Long-term Follow up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancers, Version 5.0. Monravia, CA. Children's Oncology Group. October 2018. Available on-line: http:\/\/www.survivorshipguidelines.org\/pdf\/2018\/COG_LTFU_Guidelines_v5.pdf"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0119","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbmt.2011.12.519","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"18","author":"Majhail","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0120","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbmt.2008.07.006","article-title":"Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation","volume":"14","author":"Page","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0121","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","article-title":"Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy","volume":"377","author":"Eichler","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0122","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0123","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2352-3026(17)30104-7","article-title":"Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis","volume":"4","author":"Eapen","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0124","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1196\/annals.1340.040","article-title":"Quantitative analysis of diffusion tensor imaging data in serial assessment of Krabbe disease","volume":"1064","author":"Provenzale","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0125","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.nicl.2014.09.014","article-title":"Regional differences in fiber tractography predict neurodevelopmental outcomes in neonates with infantile Krabbe disease","volume":"7","author":"Gupta","year":"2015","journal-title":"NeuroImage Clin"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0126","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3174\/ajnr.A1476","article-title":"Diffusion tensor imaging detects abnormalities in the corticospinal tracts of neonates with infantile Krabbe disease","volume":"30","author":"Escolar","year":"2009","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0127","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pediatrneurol.2013.10.001","article-title":"Patterns of magnetic resonance imaging abnormalities in symptomatic patients with Krabbe disease correspond to phenotype","volume":"50","author":"Abdelhalim","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0128","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00004691-200604000-00011","article-title":"Guidelines on visual evoked potentials","volume":"23","year":"2006","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00004691-200604000-00012","article-title":"Guideline 9C: Guidelines on short-latency auditory evoked potentials","volume":"23","year":"2006","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0130","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/WNL.0b013e31826e9ad2","article-title":"Cerebral gray and white matter changes and clinical course in metachromatic leukodystrophy","volume":"79","author":"Groeschel","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2019.09.003_bib0131","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00004691-200604000-00013","article-title":"Guidelines on short-latency somatosensory evoked potentials","volume":"23","year":"2006","journal-title":"J Clin Neurophysiol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119305713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119305713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:09:17Z","timestamp":1761059357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119305713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":131,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1083879119305713"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.09.003","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic Stem Cell Transplantation to Treat Leukodystrophies: Clinical Practice Guidelines from the Hunter's Hope Leukodystrophy Care Network","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}